<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10229820" created="22/05/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10229820</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="fibroblast_growth_factor-1" sem="Protein_molecule">Fibroblast growth factor-1</term> (<term id="T2" lex="FGF-1" sem="Protein_molecule">FGF-1</term>) enhances <term id="T3" lex="IL-2_production" sem="Other"><term id="T4" lex="IL-2" sem="Protein_molecule">IL-2</term> production</term> and <term id="T5" lex="nuclear_translocation" sem="Other"><term id="T68" sem="Cell_component">nuclear</term> translocation</term> of <term id="T6" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> in <term id="T7" lex="FGF_receptor-bearing_Jurkat_T_cell" sem="Cell_cultured"><term id="T8" lex="FGF_receptor" sem="Protein_molecule">FGF receptor</term>-bearing Jurkat T cells</term>.</sentence>
<event id="E1">
<type class="Gene_expression"/>
<theme idref="T4"/>
<clue>Fibroblast growth factor-1 (FGF-1) enhances IL-2 <clueType>production</clueType> and nuclear translocation of NF-kappaB in FGF receptor-bearing Jurkat T cells.</clue>
</event>
<event id="E2">
<type class="Localization"/>
<theme idref="T6"/>
<clue>Fibroblast growth factor-1 (FGF-1) enhances IL-2 production and <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> NF-kappaB in FGF receptor-bearing Jurkat T cells.</clue>
</event>
<event id="E3">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="T2"/>
<clue>Fibroblast growth factor-1 (FGF-1) <clueType>enhances</clueType> IL-2 production and nuclear translocation of NF-kappaB <clueLoc>in FGF receptor-bearing Jurkat T cells</clueLoc>.</clue>
</event>
<event id="E4">
<type class="Positive_regulation"/>
<theme idref="E2"/>
<cause idref="T2"/>
<clue>Fibroblast growth factor-1 (FGF-1) <clueType>enhances</clueType> IL-2 production and nuclear translocation of NF-kappaB <clueLoc>in FGF receptor-bearing Jurkat T cells</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T9" lex="fibroblast_growth_factor" sem="Protein_family_or_group">Fibroblast growth factors</term> (<term id="T10" lex="FGF" sem="Protein_family_or_group">FGFs</term>) are <term id="T11" lex="heparin-binding_protein" sem="Protein_family_or_group">heparin-binding proteins</term> crucial to <term id="T12" lex="embryogenesis" sem="Other">embryogenesis</term>, <term id="T13" lex="angiogenesis" sem="Other">angiogenesis</term>, and <term id="T14" lex="wound_healing" sem="Other">wound healing</term>.</sentence>
<event KT="Fact" id="E5">
<type class="Positive_regulation"/>
<theme idref="T12"/>
<cause idref="T10"/>
<clue>Fibroblast growth factors (FGFs) are heparin-binding proteins <clueType>crucial</clueType> <linkTheme>to</linkTheme> embryogenesis, angiogenesis, and wound healing.</clue>
</event>
<event KT="Fact" id="E6">
<type class="Positive_regulation"/>
<theme idref="T13"/>
<cause idref="T10"/>
<clue>Fibroblast growth factors (FGFs) are heparin-binding proteins <clueType>crucial</clueType> <linkTheme>to</linkTheme> embryogenesis, angiogenesis, and wound healing.</clue>
</event>
<event KT="Fact" id="E7">
<type class="Positive_regulation"/>
<theme idref="T14"/>
<cause idref="T10"/>
<clue>Fibroblast growth factors (FGFs) are heparin-binding proteins <clueType>crucial</clueType> <linkTheme>to</linkTheme> embryogenesis, angiogenesis, and wound healing.</clue>
</event>
<sentence id="S3"><term id="T15" lex="FGF-1" sem="Protein_molecule">FGF-1</term> is abundantly expressed in the synovium in <term id="T16" lex="rheumatoid_arthritis" sem="Other">rheumatoid arthritis</term> and in rejecting <term id="T17" lex="allograft" sem="Other">allografts</term>, sites of <term id="T18" lex="chronic_immune-mediated_inflammation" sem="Other">chronic immune-mediated inflammation</term>.</sentence>
<event KT="Fact" Manner="High" id="E8">
<type class="Gene_expression"/>
<theme idref="T15"/>
<clue>FGF-1 is <clueManner>abundantly</clueManner> <clueType>expressed</clueType> in the synovium in rheumatoid arthritis and in rejecting allografts, <clueLoc>sites of chronic immune-mediated inflammation</clueLoc>.</clue>
</event>
<event KT="Fact" Manner="High" id="E108">
<type class="Gene_expression"/>
<theme idref="T15"/>
<clue>FGF-1 is <clueManner>abundantly</clueManner> <clueType>expressed</clueType> <clueLoc>in the synovium in rheumatoid arthritis</clueLoc> and in rejecting allografts, sites of chronic immune-mediated inflammation.</clue>
</event>
<event KT="Fact" Manner="High" id="E208">
<type class="Gene_expression"/>
<theme idref="T15"/>
<clue>FGF-1 is <clueManner>abundantly</clueManner> <clueType>expressed</clueType> in the synovium in rheumatoid arthritis and <clueLoc>in rejecting allografts</clueLoc>, sites of chronic immune-mediated inflammation.</clue>
</event>
<sentence id="S4">The frequency of <term id="A2" sem="Cell_natural"><term id="T19" lex="FGF-1" sem="Protein_molecule">FGF-1</term>-responsive <term id="T20" lex="T_cell" sem="Cell_natural">T cells</term></term> is increased in the <term id="T21" lex="peripheral_blood" sem="Tissue_natural">peripheral blood</term> of these disorders, and a high percentage of <term id="T22" lex="infiltrating_T_cell" sem="Cell_natural">infiltrating <term id="T23" lex="T_cell" sem="Cell_natural">T cells</term></term> in <term id="T24" lex="rheumatoid_arthritis_synovium" sem="Tissue_natural"><term id="T25" lex="rheumatoid_arthritis" sem="Other">rheumatoid arthritis</term> synovium</term> express <term id="A1" sem="Protein_family_or_group">receptors for <term id="T26" lex="FGF-1" sem="Protein_molecule">FGF-1</term></term>.</sentence>
<event KT="Fact" id="E9">
<type class="Positive_regulation"/>
<theme idref="A2"/>
<clue>The frequency of FGF-1-responsive T cells is <clueType>increased</clueType> <clueLoc>in the peripheral blood of these disorders</clueLoc>, and a high percentage of infiltrating T cells in rheumatoid arthritis synovium express receptors for FGF-1.</clue>
<comment>TPS A1</comment></event>
<event KT="Fact" id="E10">
<type class="Gene_expression"/>
<theme idref="A1"/>
<clue>The frequency of FGF-1-responsive T cells is increased in the peripheral blood of these disorders, and <clueLoc>a high percentage of infiltrating T cells in rheumatoid arthritis synovium</clueLoc> <clueType>express</clueType> receptors for FGF-1.</clue>
</event>
<sentence id="S5">To understand the action of <term id="T27" lex="FGF-1" sem="Protein_molecule">FGF-1</term> in <term id="T28" lex="T_cell" sem="Cell_natural">T cells</term>, studies were initiated in <term id="T29" lex="Jurkat_T_cell" sem="Cell_cultured">Jurkat T cells</term> that express the signaling isoform of <term id="T30" lex="FGF_receptor-1" sem="Protein_molecule">FGF receptor-1</term>.</sentence>
<event KT="Other" id="E11">
<type class="Gene_expression"/>
<theme idref="T30"/>
<clue>To understand the action of FGF-1 in T cells, studies were initiated in <clueLoc>Jurkat T cells</clueLoc> that <clueType>express</clueType> the signaling isoform of FGF receptor-1.</clue>
</event>
<sentence id="S6">These experiments show that <term id="T31" lex="FGF-1" sem="Protein_molecule">FGF-1</term> stimulation of <term id="T32" lex="Jurkat_T_cell" sem="Cell_cultured">Jurkat T cells</term> provides a <term id="A4" sem="Other">second signal</term> that augments <term id="A3" sem="Protein_complex">TCR</term>-mediated <term id="T34" lex="IL-2_production" sem="Other"><term id="T35" lex="IL-2" sem="Protein_molecule">IL-2</term> production</term>.</sentence>
<event id="E12">
<type class="Physiological_process"/>
<theme idref="T32"/>
<cause idref="T31"/>
<clue>These experiments show that FGF-1 <clueType>stimulation</clueType> <linkTheme>of</linkTheme> Jurkat T cells provides a second signal that augments TCR-mediated IL-2 production.</clue>
</event>
<event KT="Other" id="E13">
<type class="Gene_expression"/>
<theme idref="T35"/>
<clue>These experiments show that FGF-1 stimulation of Jurkat T cells provides a second signal that augments TCR-mediated IL-2 <clueType>production</clueType>.</clue>
</event>
<event KT="Other" id="E14">
<type class="Positive_regulation"/>
<theme idref="E13"/>
<cause idref="A3"/>
<clue>These experiments show that FGF-1 stimulation of Jurkat T cells provides a second signal that augments TCR-<clueType>mediated</clueType> IL-2 production.</clue>
</event>
<event KT="Analysis" id="E15">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="A3"/>
<clue>These experiments <clueKT>show</clueKT> that FGF-1 stimulation of Jurkat T cells provides a second signal that <clueType>augments</clueType> TCR-mediated IL-2 production.</clue>
</event>
<event KT="Analysis" id="E16">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="E12"/>
<clue>These experiments <clueKT>show</clueKT> that FGF-1 stimulation of Jurkat T cells <clueType>provides</clueType> a second signal that augments TCR-mediated IL-2 production.</clue>
</event>
<sentence id="S7">Analogous to costimulation via <term id="T36" lex="CD28" sem="Protein_molecule">CD28</term>, this activity is mediated through activation of <term id="T37" lex="Rel/kappaB" sem="Protein_family_or_group">Rel/kappaB</term>, a family of <term id="T38" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term> known to regulate <term id="T39" lex="IL-2" sem="Protein_molecule">IL-2</term> and other <term id="T40" lex="activation-inducible_protein" sem="Protein_family_or_group">activation-inducible proteins</term>.</sentence>
<event KT="Fact" id="E17">
<type class="Regulation"/>
<theme idref="T39"/>
<cause idref="T37"/>
<clue>Analogous to costimulation via CD28, this activity is mediated through activation of Rel/kappaB, a family of transcription factors <clueKT>known</clueKT> to <clueType>regulate</clueType> IL-2 and other activation-inducible proteins.</clue>
</event>
<event KT="Fact" id="E18">
<type class="Regulation"/>
<theme idref="T40"/>
<cause idref="T37"/>
<clue>Analogous to costimulation via CD28, this activity is mediated through activation of Rel/kappaB, a family of transcription factors <clueKT>known</clueKT> to <clueType>regulate</clueType> IL-2 and other activation-inducible proteins.</clue>
</event>
<event id="E19">
<type class="Positive_regulation"/>
<theme idref="T37"/>
<clue>Analogous to costimulation via CD28, this activity is mediated through <clueType>activation</clueType> <linkTheme>of</linkTheme> Rel/kappaB, a family of transcription factors known to regulate IL-2 and other activation-inducible proteins.</clue>
</event>
<event id="E20">
<type class="Positive_regulation"/>
<theme idref="E16"/>
<cause idref="E19"/>
<clue>Analogous to costimulation via CD28, <corefTheme>this activity</corefTheme> is <clueType>mediated</clueType> <linkCause>through</linkCause> activation of Rel/kappaB, a family of transcription factors known to regulate IL-2 and other activation-inducible proteins.</clue>
</event>
<event KT="Other" id="E21">
<type class="Positive_regulation"/>
<cause idref="T36"/>
<clue>Analogous to <clueType>costimulation</clueType> <linkCause>via</linkCause> CD28, this activity is mediated through activation of Rel/kappaB, a family of transcription factors known to regulate IL-2 and other activation-inducible proteins.</clue>
</event>
<event KT="Analysis" id="E22">
<type class="Positive_regulation"/>
<theme idref="E21"/>
<cause idref="E19"/>
<clue><linkTheme><clueKT>Analogous</clueKT> to</linkTheme> costimulation via CD28, this activity is <clueType>mediated</clueType> <linkCause>through</linkCause> activation of Rel/kappaB, a family of transcription factors known to regulate IL-2 and other activation-inducible proteins.</clue>
</event>
<sentence id="S8"><term id="T41" lex="FGF-1" sem="Protein_molecule">FGF-1</term> alone induces modest nuclear translocation of <term id="T42" lex="kappaB-binding_protein" sem="Protein_family_or_group">kappaB-binding proteins</term>, and this translocation is enhanced by the combination of <term id="T43" lex="anti-CD3" sem="Protein_family_or_group">anti-CD3</term> and <term id="T44" lex="FGF-1" sem="Protein_molecule">FGF-1</term>.</sentence>
<event Manner="Low" id="E23">
<type class="Localization"/>
<theme idref="T42"/>
<clue>FGF-1 alone induces <clueManner>modest</clueManner> <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> kappaB-binding proteins, and this translocation is enhanced by the combination of anti-CD3 and FGF-1.</clue>
</event>
<event id="E24">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<cause idref="T41"/>
<clue>FGF-1 alone <clueType>induces</clueType> modest nuclear translocation of kappaB-binding proteins, and this translocation is enhanced by the combination of anti-CD3 and FGF-1.</clue>
</event>
<event id="E25">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<cause idref="T43"/>
<cause idref="T44"/>
<clue>FGF-1 alone induces modest nuclear translocation of kappaB-binding proteins, and <corefTheme>this translocation</corefTheme> is <clueType>enhanced</clueType> <linkCause>by the combination of</linkCause> anti-CD3 and FGF-1.</clue>
</event>
<sentence id="S9">This <term id="T45" lex="NF-kappaB_binding_complex" sem="Protein_complex"><term id="T46" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> binding complex</term> is composed of <term id="T47" lex="transcriptionally_active_p65(RelA)/p50_heterodimer" sem="Protein_complex">transcriptionally active <term id="A5" sem="Protein_molecule">p65</term>(<term id="T48" lex="RelA" sem="Protein_molecule">RelA</term>)/<term id="A6" sem="Protein_molecule">p50</term> heterodimers</term> and results primarily from the targeted degradation of <term id="T49" lex="IkappaB-alpha" sem="Protein_molecule">IkappaB-alpha</term>, an inhibitor that sequesters <term id="T50" lex="Rel/kappaB" sem="Protein_family_or_group">Rel/kappaB</term> in the <term id="T51" lex="cytoplasm" sem="Cell_component">cytoplasm</term>.</sentence>
<event id="E26">
<type class="Protein_catabolism"/>
<theme idref="T49"/>
<clue>This NF-kappaB binding complex is composed of transcriptionally active p65(RelA)/p50 heterodimers and results primarily from the targeted <clueType>degradation</clueType> <linkTheme>of</linkTheme> IkappaB-alpha, an inhibitor that sequesters Rel/kappaB in the cytoplasm.</clue>
</event>
<event id="E27">
<type class="Positive_regulation"/>
<theme idref="T45"/>
<clue>This NF-kappaB binding complex is <clueType>composed</clueType> of transcriptionally active p65(RelA)/p50 heterodimers and results primarily from the targeted degradation of IkappaB-alpha, an inhibitor that sequesters Rel/kappaB in the cytoplasm.</clue>
</event>
<event id="E28">
<type class="Positive_regulation"/>
<theme idref="E27"/>
<cause idref="E26"/>
<clue>This NF-kappaB binding complex is composed of transcriptionally active p65(RelA)/p50 heterodimers and <clueType>results</clueType> primarily <linkCause>from</linkCause> the targeted degradation of IkappaB-alpha, an inhibitor that sequesters Rel/kappaB in the cytoplasm.</clue>
</event>
<event KT="Fact" id="E29">
<type class="Localization"/>
<theme idref="T50"/>
<clue>This NF-kappaB binding complex is composed of transcriptionally active p65(RelA)/p50 heterodimers and results primarily from the targeted degradation of IkappaB-alpha, an inhibitor that <clueType>sequesters</clueType> Rel/kappaB <clueLoc>in the cytoplasm</clueLoc>.</clue>
</event>
<event KT="Fact" id="E101">
<type class="Positive_regulation"/>
<theme idref="E29"/>
<cause idref="T49"/>
<clue>This NF-kappaB binding complex is composed of transcriptionally active p65(RelA)/p50 heterodimers and results primarily from the targeted degradation of IkappaB-alpha, <corefCause>an inhibitor</corefCause> that sequesters Rel/kappaB in the cytoplasm.</clue>
<comment>No clueType</comment></event>
<sentence id="S10">These data are the first to show a connection between <term id="T52" lex="FGF-1" sem="Protein_molecule">FGF-1</term> signaling and <term id="T53" lex="NF-kappaB_activation" sem="Other"><term id="T54" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> activation</term> outside of <term id="T55" lex="embryonic_development" sem="Other">embryonic development</term>.</sentence>
<event KT="Other" id="E30">
<type class="Positive_regulation"/>
<theme idref="T54"/>
<clue>These data are the first to show a connection between FGF-1 signaling and NF-kappaB <clueType>activation</clueType> outside of embryonic development.</clue>
</event>
<event KT="Other" id="E31">
<type class="Cell_communication"/>
<theme idref="T52"/>
<clue>These data are the first to show a connection between FGF-1 <clueType>signaling</clueType> and NF-kappaB activation outside of embryonic development.</clue>
</event>
<event KT="Analysis" id="E32">
<type class="Correlation"/>
<theme idref="E31"/>
<theme idref="E30"/>
<clue>These data are the first to <clueKT>show</clueKT> a <clueType>connection</clueType> <linkTheme>between</linkTheme> FGF-1 signaling and NF-kappaB activation outside of embryonic development.</clue>
</event>
<sentence id="S11">The <term id="A7" sem="Other">signaling events</term> that link <term id="T56" lex="FGF_receptor-1" sem="Protein_molecule">FGF receptor-1</term> engagement and <term id="T57" lex="NF-kappaB_activation" sem="Other"><term id="T58" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> activation</term> in <term id="T59" lex="Jurkat" sem="Cell_cultured">Jurkat</term> are probably distinct from the <term id="T60" lex="CD28_costimulation_pathway" sem="Other"><term id="T61" lex="CD28" sem="Protein_molecule">CD28</term> costimulation pathway</term>, since <term id="T62" lex="FGF-1" sem="Protein_molecule">FGF-1</term>-induced <term id="T63" lex="Rel/kappaB_binding_protein" sem="Protein_family_or_group"><term id="T64" lex="Rel/kappaB" sem="Protein_family_or_group">Rel/kappaB</term> binding proteins</term> do not contain significant levels of <term id="T65" lex="c-Rel" sem="Protein_molecule">c-Rel</term> and are not identical with the <term id="T66" lex="CD28_response_complex" sem="Protein_complex"><term id="T67" lex="CD28" sem="Protein_molecule">CD28</term> response complex</term>.</sentence>
<event id="E33">
<type class="Binding"/>
<theme idref="T56"/>
<clue>The signaling events that link FGF receptor-1 <clueType>engagement</clueType> and NF-kappaB activation in Jurkat are probably distinct from the CD28 costimulation pathway, since FGF-1-induced Rel/kappaB binding proteins do not contain significant levels of c-Rel and are not identical with the CD28 response complex.</clue>
</event>
<event id="E34">
<type class="Positive_regulation"/>
<theme idref="T58"/>
<clue>The signaling events that link FGF receptor-1 engagement and NF-kappaB <clueType>activation</clueType> in Jurkat are probably distinct from the CD28 costimulation pathway, since FGF-1-induced Rel/kappaB binding proteins do not contain significant levels of c-Rel and are not identical with the CD28 response complex.</clue>
</event>
<event id="E35">
<type class="Correlation"/>
<theme idref="E33"/>
<theme idref="E34"/>
<theme idref="A7"/>
<clue>The signaling events that <clueType>link</clueType> FGF receptor-1 engagement and NF-kappaB activation <clueLoc>in Jurkat</clueLoc> are probably distinct from the CD28 costimulation pathway, since FGF-1-induced Rel/kappaB binding proteins do not contain significant levels of c-Rel and are not identical with the CD28 response complex.</clue>
</event>
<event KT="Other" id="E36">
<type class="Positive_regulation"/>
<theme idref="T63"/>
<cause idref="T62"/>
<clue>The signaling events that link FGF receptor-1 engagement and NF-kappaB activation in Jurkat are probably distinct from the CD28 costimulation pathway, since FGF-1-<clueType>induced</clueType> Rel/kappaB binding proteins do not contain significant levels of c-Rel and are not identical with the CD28 response complex.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
